Rhythm Biosciences Limited (RHY.AX)

0.0840 0.0000 (0.00%) At close: 03:58PM AEST

Rhythm Biosciences Limited

Bio21 Institute
30 Flemington Road
Parkville, VIC 3010
Australia
61 3 8256 2880
https://www.rhythmbio.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Otto Leslie-Steven Buttula AIMM, B.Ec., Grad. Dip., MAICD	Executive Chairman	182.32k	N/A	1964
Mr. Guy Carisbrooke	Financial Controller	N/A	N/A	N/A
Ms. Andrea Steele LLB B Com LLM	General Counsel & Joint Company Secretary	N/A	N/A	N/A
Ms. Elena Deak	Chief Commercial Officer	N/A	N/A	N/A
Mr. James Stephen Barrie CPA	Joint Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Rhythm Biosciences Limited, engages in developing and commercializing medical diagnostics technology in Australia and internationally. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Parkville, Australia.

Corporate governance

Rhythm Biosciences Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.